StreetAlpha.app
Home › Stocks › BIO

Bio-rad Laboratories, Inc. (BIO)

Healthcare
Members
LATEST PRICE

Bio-Rad makes life science research tools and clinical diagnostic test systems for labs, hospitals and research institutions. BIO reports earnings on Wed, Nov 4, 2026. Analyst consensus is Hold, based on the latest ratings from 3 firms (1 buy, 2 hold, 0 sell).

Prices, price targets and earnings estimates for BIO are shown to AI Starter and AI Pro members. Ratings, flow and news are open to everyone.See plans
AI Auto Pilots
Is BIO in one of our four AI portfolios? Sign in free to see
Next report
Nov 4
2026 · Time not announced
Consensus EPS forecast
EPS and revenue estimates
Year-ago EPS
Same quarter last year
Options-implied move
Move priced in by options
Analyst consensus
Hold
Based on 3 analyst ratings (90 days)
Loading…

Analyst Ratings & Price Targets

Analyst Ratings →
Consensus · 90 days
Hold
3firms
1 Buy2 Hold0 Sell
Each firm's latest rating on BIO in the past 90 days
Average 12-month target
Price targets for BIOThe average, highest and lowest analyst targets and the target chart are shown to AI Starter and AI Pro members.See plans
Latest rating changes
RBC CapitalTarget raised
Aug 7Buy
CitigroupMaintained
Aug 5Hold
RBC CapitalTarget raised
Aug 5Buy
Wells FargoMaintained
Aug 5Hold
RBC CapitalReinstated
May 15Buy
DateFirmActionRatingPrice target
Aug 7RBC CapitalTarget raisedBuy
Aug 5CitigroupMaintainedHold
Aug 5RBC CapitalTarget raisedBuy
Aug 5Wells FargoMaintainedHold
May 15RBC CapitalReinstatedBuy
Loading…

Whale Options Flow

90D

No whale options trades in BIO in the last 90 days.

Loading…

AI Auto Pilots

Paper trading

StreetAlpha runs four autonomous AI traders powered by Anthropic's Claude. Each one reads options flow, dark pool prints, insider filings, sentiment, macro signals and technicals, then makes its own trading decisions in a paper portfolio. Every decision is logged and every trade is tracked, so you can see whether BIO is in one of them and how their past BIO trades turned out.

BIO in the AI portfolios
Loading…

Macro & Market News

All StreetAlpha news →

StreetAlpha hasn't covered BIO in an article yet. Here's the latest on the wider market.

BIO Congress Trades

All congress trades →
Trades, 12 months
1
Buys
0
0%
Sells
1
100%
People
1
Last filed Apr 10
Who traded BIO · since 2015
Latest 5 filings of 28
$1K – $15KTraded Jan 30, 2026Filed Apr 10, 2026
$1K – $15KTraded Apr 28, 2025Filed Sep 9, 2025
$1K – $15KTraded Nov 3, 2023Filed Dec 6, 2023
$15K – $50KTraded Oct 26, 2023Filed Nov 8, 2023
$1K – $15KTraded Oct 2, 2023Filed Nov 8, 2023
PersonTypeAmountTradedFiledDelay
Arjun ModyExecutive branchSell$1K – $15KJan 30, 2026Apr 10, 202670 d
Lori Chavez-DeRemerExecutive branchSell$1K – $15KApr 28, 2025Sep 9, 2025134 d
Ro KhannaD · CASell$1K – $15KNov 3, 2023Dec 6, 202333 d
Ro KhannaD · CASell$15K – $50KOct 26, 2023Nov 8, 202313 d
Ro KhannaD · CABuy$1K – $15KOct 2, 2023Nov 8, 202337 d

Members of Congress and senior officials report trades up to 45 days later, as dollar ranges. Filings show a trade happened, not why. Not investment advice.

About Bio-rad Laboratories

Bio-Rad is a life science and clinical diagnostics company based in Hercules, California. Its life science unit makes instruments, systems, reagents, and consumables used to separate, purify, and measure cells, proteins, and nucleic acids. Its diagnostics unit supplies test systems, software, test kits, and quality controls for the in vitro diagnostics market. Customers include universities, research institutions, pharmaceutical and biotechnology companies, hospital and reference laboratories, and food testing labs.

Headquarters
Hercules, CA
Founded
1952